Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Braz J Microbiol ; 51(4): 1665-1672, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32557281

ABSTRACT

With the high-frequency use or abuse of antifungal drugs, the crisis of drug-resistant fungi continues to increase worldwide; in particular, the infection of drug-resistant Candida albicans brings the great challenge to the clinical treatment. Therefore, to decelerate the spread of this resistance, it is extremely urgent to facilitate the new antifungal targets with novel drugs. Phosphopantetheinyl transferases PPTases (Ppt2 in Candida albicans) had been identified in bacterium and fungi and mammals, effects as a vital enzyme in the metabolism of organisms in C. albicans. Ppt2 transfers the phosphopantetheinyl group of coenzyme A to the acyl carrier protein Acp1 in mitochondria for the synthesis of lipoic acid that is essential for fungal respiration, so making Ppt2 an ideal target for antifungal drugs. In this study, 110 FDA-approved drugs were utilized to investigate the Ppt2 inhibition against drug-resistant Candida albicans by the improved fluorescence polarization experiments, which have enough druggability and structural variety under the novel strategy of drug repurposing. Thereinto, eight agents revealed the favourable Ppt2 inhibitory activities. Further, broth microdilution assay of incubating C. albicans with these eight drugs showed that pterostilbene, procyanidine, dichlorophen and tea polyphenol had the superior MIC values. In summary, these findings provide more valuable insight into the treatment of drug-resistant C. albicans.


Subject(s)
Antifungal Agents/pharmacology , Candida albicans/drug effects , Drug Resistance, Fungal/drug effects , Enzyme Inhibitors/pharmacology , Transferases (Other Substituted Phosphate Groups)/antagonists & inhibitors , Candida albicans/enzymology , Drug Repositioning , Fungal Proteins/antagonists & inhibitors , Microbial Sensitivity Tests
2.
Biochim Biophys Acta Mol Cell Res ; 1865(2): 309-322, 2018 Feb.
Article in English | MEDLINE | ID: mdl-29128370

ABSTRACT

Epithelial tissue requires that cells attach to each other and to the extracellular matrix by the assembly of adherens junctions (AJ) and focal adhesions (FA) respectively. We have previously shown that, in renal papillary collecting duct (CD) cells, both AJ and FA are located in sphingomyelin (SM)-enriched plasma membrane microdomains. In the present work, we investigated the involvement of SM metabolism in the preservation of the epithelial cell phenotype and tissue organization. To this end, primary cultures of renal papillary CD cells were performed. Cultured cells preserved the fully differentiated epithelial phenotype as reflected by the presence of primary cilia. Cells were then incubated for 24h with increasing concentrations of D609, a SM synthase (SMS) inhibitor. Knock-down experiments silencing SMS 1 and 2 were also performed. By combining biochemical and immunofluorescence studies, we found experimental evidences suggesting that, in CD cells, SMS 1 activity is essential for the preservation of cell-cell adhesion structures and therefore for the maintenance of CD tissue/tubular organization. The inhibition of SMS 1 activity induced CD cells to lose their epithelial phenotype and to undergo an epithelial-mesenchymal transition (EMT) process.


Subject(s)
Epithelial Cells/enzymology , Epithelial-Mesenchymal Transition , Kidney Tubules, Collecting/enzymology , Transferases (Other Substituted Phosphate Groups)/antagonists & inhibitors , Animals , Cell Adhesion , Epithelial Cells/cytology , Kidney Tubules, Collecting/cytology , Male , Rats , Rats, Wistar , Transferases (Other Substituted Phosphate Groups)/metabolism
3.
J Lipid Res ; 56(4): 786-800, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25670801

ABSTRACT

Sphingolipids (SLs) are relevant lipid components of eukaryotic cells. Besides regulating various cellular processes, SLs provide the structural framework for plasma membrane organization. Particularly, SM is associated with detergent-resistant microdomains. We have previously shown that the adherens junction (AJ) complex, the relevant cell-cell adhesion structure involved in cell differentiation and tissue organization, is located in an SM-rich membrane lipid domain. We have also demonstrated that under hypertonic conditions, Madin-Darby canine kidney (MDCK) cells acquire a differentiated phenotype with changes in SL metabolism. For these reasons, we decided to evaluate whether SM metabolism is involved in the acquisition of the differentiated phenotype of MDCK cells. We found that SM synthesis mediated by SM synthase 1 is involved in hypertonicity-induced formation of mature AJs, necessary for correct epithelial cell differentiation. Inhibition of SM synthesis impaired the acquisition of mature AJs, evoking a disintegration-like process reflected by the dissipation of E-cadherin and ß- and α-catenins from the AJ complex. As a consequence, MDCK cells did not develop the hypertonicity-induced differentiated epithelial cell phenotype.


Subject(s)
Cell Differentiation , Osmotic Pressure , Sphingomyelins/metabolism , Adherens Junctions/drug effects , Adherens Junctions/metabolism , Animals , Cadherins/metabolism , Cell Differentiation/drug effects , Cell Nucleus/drug effects , Cell Nucleus/metabolism , Dogs , Dose-Response Relationship, Drug , Enzyme Inhibitors/pharmacology , Gene Expression Regulation, Enzymologic/drug effects , Gene Knockdown Techniques , Madin Darby Canine Kidney Cells , Phenotype , Transferases (Other Substituted Phosphate Groups)/antagonists & inhibitors , Transferases (Other Substituted Phosphate Groups)/deficiency , Transferases (Other Substituted Phosphate Groups)/genetics , Transferases (Other Substituted Phosphate Groups)/metabolism , alpha Catenin/metabolism , beta Catenin/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL